Aldeyra Therapeutics
Lisa Chan is a seasoned accounting professional with extensive experience in the biotech and technology sectors. Currently serving as a Senior Accountant at Aldeyra Therapeutics since June 2022, Lisa previously held several senior and staff accounting roles at T2 Biosystems from May 2015 to June 2022. Earlier in their career, Lisa worked as a Staff Accountant at NetCracker Technology from February 2011 to October 2014. Lisa Chan earned a Bachelor of Science degree in Business Administration and Management from the University of Massachusetts Lowell between 2002 and 2005.
Aldeyra Therapeutics
3 followers
Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.